fashion -WSS

fashion

author：knowledge 2025-10-01 14:20:14 - browse：88346

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Wikipedia

WSS

Colonoscopy prep: Liquid

4 missing after record

Plastic surgeons increase patient psychiatric screenings

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Thousands protest mob assault of women who were paraded naked in remote Indian border state

Doctors have an ethical obligation to be advocates

entertainment

fashion

explore

Jerome Adams on the need for new antivirals for Covid

The response to Covid

Hepatitis C has a cure — but many Americans still lack access to it

Nurses recount patients attacks

How one medical school became remarkably diverse

Burning questions about Delta and the next phase of the Covid pandemic

Drug repurposing or repositioning? The language matters

Orchard's therapy for neuron disease in children wins FDA approval

Hepatitis C has a cure — but many Americans still lack access to it

My chronic pain journey would have been easier knowing 5 things % STAT

focus

What Henrietta Lacks's story taught me about my role as a doctor

5 to watch: Tech startups trying to solve health care's staffing crisis

App could help diagnose ear infections more accurately — and at home

Virtual Event: March of the Biosimilars

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

leisure time

Wikipedia

hotspot

entertainment